The present work now identified that high CCNE1 mRNA levels also reduced the postcurative survival of HCC patients, illustrating CCNE1 expression as a relevant marker to predict therapeutic prognosis. This evidence concerns the gene CCNE1 and hepatocellular carcinoma.